NFKB1 and inflammation: By this rationale, our findings do not refute prior work that inhibition of NF-κB in the context of pathological vascular inflammation improves insulin sensitivity41, nor do they discount the possibility that overexpression of Sirt1 in a similar context, such as high-fat diet-induced vascular inflammation, may improve glycemic control.